Hims & Hers (HIMS +0.00%) announced the $1.15 billion acquisition of Australian telehealth company Eucalyptus, which will add $450 million in annualized revenue to the company. This isn’t a company shying away from recent legal action, it’s scaling internationally as fast as possible. In this video, I go through the upside from this acquisition as well as the downside of using most of the cash on the balance sheet, which was once a backstop for investors.
*Stock prices used were end-of-day prices of Feb. 19, 2026. The video was published on Feb. 19, 2026.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hims & Hers HUGE Acquisition News!
Hims & Hers (HIMS +0.00%) announced the $1.15 billion acquisition of Australian telehealth company Eucalyptus, which will add $450 million in annualized revenue to the company. This isn’t a company shying away from recent legal action, it’s scaling internationally as fast as possible. In this video, I go through the upside from this acquisition as well as the downside of using most of the cash on the balance sheet, which was once a backstop for investors.
*Stock prices used were end-of-day prices of Feb. 19, 2026. The video was published on Feb. 19, 2026.